69
Participants
Start Date
July 13, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
DR-01
DR-01 is a non-fucosylated, human immunoglobulin G1 (IgG1) monoclonal antibody.
RECRUITING
Dren Investigational Site, Richmond
RECRUITING
Dren Investigational Site, Clayton
RECRUITING
Dren Investigational Site, Nedlands
RECRUITING
Dren Investigational Site 1, New York
NOT_YET_RECRUITING
Dren Investigational Site 2, New York
RECRUITING
Dren Investigational Site, Berlin
RECRUITING
Dren Investigational Site 2, Pittsburgh
RECRUITING
Dren Investigational Site, Fairfax
RECRUITING
Dren Investigational Site, Charlottesville
RECRUITING
Dren Investigational Site, Toulouse
RECRUITING
Dren Investigational Site, Tampa
RECRUITING
Dren Investigational Site, Rennes
RECRUITING
Dren Investigational Site, Birmingham
RECRUITING
Dren Investigational Site, Salamanca
RECRUITING
Dren Investigational Site, Bologna
RECRUITING
Dren Investigational Site, Columbus
NOT_YET_RECRUITING
Dren Investigational Site, Cologne
RECRUITING
Dren Investigational Site, Pierre-Bénite
RECRUITING
Dren Investigational Site, Houston
RECRUITING
Dren Investigational Site, Duarte
RECRUITING
Dren Investigational Site, Redwood City
RECRUITING
Dren Investigational Site, Seattle
RECRUITING
Dren Investigational Site, New Haven
NOT_YET_RECRUITING
Dren Investigational Site, Boston
RECRUITING
Dren Investigational Site, Leipzig
RECRUITING
Dren Investigational Site 1, Hong Kong
RECRUITING
Dren Investigational Site 2, Hong Kong
RECRUITING
Dren Investigational Site 1, Busan
RECRUITING
Dren Investigational Site 2, Busan
RECRUITING
Dren Investigational Site, Goyang-si
RECRUITING
Dren Investigational Site 1, Seoul
RECRUITING
Dren Investigational Site 2, Seoul
RECRUITING
Dren Investigational Site 3, Seoul
RECRUITING
Dren Investigational Site, Tainan City
RECRUITING
Dren Investigational Site, Taipei
RECRUITING
Dren Investigational Site, Barcelona
Lead Sponsor
Dren Bio
INDUSTRY